AMD announced its first life sciences collaboration with AI-based drug developer Absci, providing its hardware and software for Absci’s AI drug discovery. Despite AMD also investing $20m in Absci, its shares fell 4% after HSBC analyst Frank Lee downgraded the firm from “Buy” to “Reduce” and cut its price target by 18%, suggesting AMD will continue trailing market leader Nvidia. This is AMD’s first life-sciences partnership.
Outlaw Group Uses SSH Brute-Force to Deploy Cryptojacking Malware on Linux Servers
Cybersecurity researchers have revealed details about Outlaw, an “auto-propagating” cryptocurrency mining botnet that targets SSH servers with weak credentials. The Romanian-origin malware performs SSH brute-force
